<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-vaccines-08-00115">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bossart</surname>
    <given-names>K.N.</given-names>
   </name>
   <name>
    <surname>Crameri</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Dimitrov</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Mungall</surname>
    <given-names>B.A.</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>Y.-R.</given-names>
   </name>
   <name>
    <surname>Patch</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Choudhary</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.-F.</given-names>
   </name>
   <name>
    <surname>Eaton</surname>
    <given-names>B.T.</given-names>
   </name>
   <name>
    <surname>Broder</surname>
    <given-names>C.C.</given-names>
   </name>
  </person-group>
  <article-title>Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of 
   <italic>Hendra virus</italic>
  </article-title>
  <source>J. Virol.</source>
  <year>2005</year>
  <volume>79</volume>
  <fpage>6690</fpage>
  <lpage>6702</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.79.11.6690-6702.2005</pub-id>
  <pub-id pub-id-type="pmid">15890907</pub-id>
 </element-citation>
</ref>
